Test Price
1,500 AED✅ Home Collection Available
Mastitis Partial Panel with β‑Lactamase Penicillin Resistance Profile PCR Test in UAE | 1500 AED | DHA Licensed
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity: ISO‑accredited molecular detection guarantees near‑certain identification of mastitis‑causing pathogens and β‑lactamase resistance determinants.
Hospital-Based Specimen Collection: Fine‑needle aspiration or breast milk expression performed at an accredited medical facility under sterile conditions; mobile home phlebotomy is not available for this invasive procedure.
Post‑Test Clinical Guidance: Dedicated telephonic consultation with an expert physician to interpret results and plan immediate next steps.
Direct Insurance Billing: Verification via WhatsApp at +971 54 548 8731 — seamless processing with all major UAE insurers.
Test Overview & Methodology
The Mastitis Partial Panel with β‑Lactamase Penicillin Resistance Profile PCR Test is a multiplex real‑time PCR assay that simultaneously detects common mastitis‑causing bacteria (e.g., Staphylococcus aureus, Streptococcus spp.) and the presence of the β‑lactamase gene conferring penicillin resistance. This dual‑target approach is essential for patients with suspected infectious mastitis, especially when differentiating from inflammatory breast carcinoma or when rapid antibiotic stewardship is required.
| Feature | Our Test (Premium Panel) | Conventional Culture & Sensitivity |
|---|---|---|
| Technology | Multiplex Real‑Time PCR with melt‑curve analysis | Microbiological culture + disc diffusion |
| Turnaround Time | 1 week (expedited genomic detection) | 3–5 days for growth, additional 24–48 h for sensitivity |
| Resistance Detection | Direct β‑lactamase gene identification | Indirect inference via phenotypic resistance |
| Clinical Relevance | Highly specific; reduces empirical antibiotic use | May miss non‑culturable or fastidious organisms |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor (DHA Registration ID: 61713011, Specialist Diagnostic Radiology) notes: "A positive β‑lactamase PCR result may indicate penicillin resistance, but concurrent imaging and histopathological evaluation remain essential to exclude inflammatory breast carcinoma. This test serves as a powerful adjunct in the clinical risk assessment of mastitis, enabling early targeted antimicrobial therapy and reducing the likelihood of sepsis progression."
Medication Safety Advisory
⚠️ MEDICATION SAFETY: Do not discontinue or alter any prescribed antibiotic, chemotherapy, or hormonal therapy without explicit instruction from your attending physician. Premature interruption can worsen resistance or mask cancer progression.
Exclusion Criteria & Emergency Red Flags
- Inability to provide a breast milk aspirate or tissue sample (absolute contraindication to fine‑needle aspiration or core biopsy).
- Known severe coagulopathy (INR > 2.0, platelets < 50×10⁹/L) without haematology clearance.
- Progressive cellulitis extending beyond the breast quadrant or signs of necrotizing fasciitis.
- Fever > 38.5°C with rigors, tachycardia, or hypotension — proceed directly to emergency care.
- Development of a painful fluctuant mass with systemic toxicity (possible abscess requiring urgent surgical drainage).
Patient FAQ & Clinical Guidance
1. What exactly does the β‑lactamase resistance result tell my doctor?
This test directly detects the genetic sequence of the β‑lactamase enzyme, giving your physician a clear indication: "Beta‑lactamase gene detected signals penicillin resistance, guiding immediate selection of an alternative antibiotic therapy if clinically warranted."
2. Is the sample collection painful and what should I expect during the hospital visit?
A sterile, fine‑needle aspiration or breast milk expression is used; the procedure is performed at an accredited facility by a qualified clinician. Most patients report minimal discomfort, and no downtime is required afterward.
3. How soon can I start targeted treatment after receiving the PCR result?
Once the report is issued (1 week), the post‑test clinical consultation provides immediate guidance. You receive telephonic interpretation within 24 hours of report release, enabling same‑day therapy modification if clinically needed.
UAE Regulatory & Data Privacy Adherence
All testing performed under the authority of DHA Facility License 1143. Clinical safety and patient consent procedures conform to Federal Decree-Law No. 4 of 2016 on Medical Liability. Patient data is handled in strict accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Laboratory accredited to ISO 9001:2015 (Certificate: INT/EGQ/2509DA/3139), ensuring the highest quality management standards.
Clinical & Logistical Metadata
| Test Name | Mastitis Partial Panel with β‑Lactamase Penicillin Resistance Profile PCR Test |
| Price (AED) | 1500 |
| Turnaround Time | 1 week |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Multiplex Real‑Time PCR with melt‑curve analysis |
| ICD-10-CM Code | N61 |
| LOINC Code | 100396-3 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians